The Effectiveness of a Smartphone App on Medication Adherence and Psychotic Symptoms and Cognitive Functions in Patients With Schizophrenia
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Medication Adherence
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Medication adherence rate
- Status
- Enrolling by Invitation
- Last Updated
- 2 years ago
Overview
Brief Summary
This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
Detailed Description
Schizophrenia is a mental disorder that causes severe functional disabilities and imposes a heavy economic burden. Poor medication adherence is one of the major causes of relapse of psychiatric symptoms in schizophrenic patients. This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
Investigators
Eligibility Criteria
Inclusion Criteria
- •schizophrenia
- •aged 20 to 65 years
- •able to read traditional Chinese
- •owning a smartphone
- •currently admitted at a psychiatric day-care center
Exclusion Criteria
- •Intellectually disabled or severe cognitive function impairment (Dementia)
Outcomes
Primary Outcomes
Medication adherence rate
Time Frame: Change from Baseline Medication adherence' rate at 8 weeks
Utilizing cloud-based platforms to compute the medication adherence rate.
psychiatric symptoms
Time Frame: Change from Baseline psychiatric symptoms at 8 weeks
The positive and negative syndrome scale was used to measure participants' psychiatric symptoms. Of the 30 items on the scale, seven are positive symptoms, seven are negative symptoms, and 16 are general psychopathology symptoms. Symptom severity for each item is rated according to the anchoring points in the 7-point scale (1 = absent; 7 = extreme) that best describe the symptom (Kay et al., 1987). The PANSS score is the sum of ratings across items, ranging from 7 to 49 for the Positive, Negative Scales, and 16 to 112 and 16 to 112 for the General Psychopathology Scale.
cognitive functions
Time Frame: Change from Baseline cognitive functions at 8 weeks
The Mini-Mental State Examination was used to measure participants' cognitive functions. The MMSE consists of 15 questions for assessing the following seven cognitive domains: orientation in time and place, memory registration and recall, attention and calculation, and language. The total MMSE score ranged from 0 to 30, and higher scores indicate better cognitive functions.